Publications
5539 Results
- Journal / Conference
- Journal of Clinical Oncology 19(2):448-457
- Year
- 2001
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9323 (E4592)
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a lab ancillary study on an Eastern Cooperative Oncology Group prospective randomized trial of postop adjuvant therapy
- Journal / Conference
- Journal of Clinical Oncology 19(16):3611-3621
- Year
- 2001
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9108 (CALGB-9011)
Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
- Journal / Conference
- Journal of Clinical Oncology 19(4):1001-1007
- Year
- 2001
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9227 (GOG-114)
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small volume stage III ovarian carcinoma: An intergroup stud y of the GOG, SWOG, and ECOG
- Journal / Conference
- Leukemia 15:208-216
- Year
- 2001
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8417/19
Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group study
- Journal / Conference
- Investigational New Drugs 19:239-243
- Year
- 2001
- Research Committee(s)
- Melanoma
- Study Number(s)
- S9622
Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy: a Southwest Oncology Group Study
- Journal / Conference
- Investigational New Drugs 19:311-315
- Year
- 2001
- Research Committee(s)
- Head and Neck
- Study Number(s)
- S9708
Evaluation of gemcitibine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group Phase II study.
- Journal / Conference
- Lung Cancer 33:213-219
- Year
- 2001
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8269
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer
- Journal / Conference
- Clinical Cancer Research 7:2325-2329
- Year
- 2001
- Research Committee(s)
- Lung
- Study Number(s)
- S9705
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group 1,2
- Journal / Conference
- Blood 97(12):3713-3720
- Year
- 2001
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8516 (INT-0067)
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic and clinical features
- Journal / Conference
- Blood 97(11):3589-3595
- Year
- 2001
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9031